(Q36107245)

12 August 2017

1 reference

title

Verbal memory deficit in patients with schizophrenia: an important future target for treatment (English)

1 reference

12 August 2017

0 references

Robin M Murray

2

0 references

author name string

Timothea Toulopoulouand

series ordinal

1

1 reference

12 August 2017

publication date

1 January 2004

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

12 August 2017

published in

1 reference

12 August 2017

volume

4

1 reference

12 August 2017

issue

1

1 reference

12 August 2017

page(s)

43-52

1 reference

Neuropsychological functioning in first-episode psychosis--evidence of specific deficits.

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

Longitudinal study of symptoms and cognitive function in chronic schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

Episodic memory in schizophrenic patients and their relatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

The inheritance of neuropsychological dysfunction in twins discordant for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

Neuropsychological impairments in neuroleptic-responder vs. -nonresponder schizophrenic patients and healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

Emotional discomfort and impairments in verbal memory in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

Schizophrenia and memory impairment: evidence for a neurocognitive subtype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

Neurocognition and community outcome in schizophrenia: long-term predictive validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

Episodic memory: from mind to brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

Negative symptom resolution and improvements in specific cognitive deficits after acute treatment in first-episode schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

Neuropsychological functioning in elderly patients with schizophrenia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

Memory and organizational strategies in chronic and acute schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

Learning and forgetting in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

Memory and schizophrenia: differential link of processing speed and selective attention with two levels of encoding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

A comparison of memory for verbal and non-verbal material in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

Deficits in language-mediated mental operations in patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

Neuropsychological functioning among non-psychotic siblings and parents of schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: the New York High-Risk Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

Neuropsychological change in young people at high risk for schizophrenia: results from the first two neuropsychological assessments of the Edinburgh High Risk Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

Neuroimaging of declarative memory in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

Functional neuroimaging studies of encoding, priming, and explicit memory retrieval

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

Common prefrontal activations during working memory, episodic memory, and semantic memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

Integrated brain activity in medial temporal and prefrontal areas predicts subsequent memory performance: human declarative memory formation at the system level

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

Reduced hippocampal activation during encoding and recognition of words in schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

Impaired hippocampal recruitment during normal modulation of memory performance in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

Cognitive effects and antipsychotic treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

Clozapine enhances neurocognition and clinical symptomatology more than standard neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

The effect of tandospirone, a serotonin(1A) agonist, on memory function in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

Glucose-induced increase in memory performance in patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

Is it possible to be schizophrenic yet neuropsychologically normal?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.43

21 January 2018

Identifiers

DOI

10.1586/14737175.4.1.43

1 reference

12 August 2017

1 reference